GL1X · GenesisL1 explorer

MolNFT v1 · #88479 · protein

Crystal structure of cofactor-free urate oxidase in complex with the 5-peroxo derivative of 9-metyl uric acid (X-ray dose, 665 kgy)

4CW3 · Uricase: “Crystal structure of cofactor-free urate oxidase in complex with the 5-peroxo derivative of 9-metyl uric acid…”. X-ray diffraction, 3 ligands (XDS, MUA, OXY), 2 pockets (best druggability 0.55). MolNFT v1 #88479 on…

PDB
4CW3
Type
protein
Length
301 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Uricase
EC
1.7.3.3
UniProt
Q00511
Ligands
XDS, MUA, OXY
Pockets
2 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 27% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUricase (EC 1.7.3.3)protein30127% helix, 38% strandQ00511

Ligands and binding sites

  • XDS · (5S)-5-(dioxidanyl)-9-methyl-7H-purine-2,6,8-trione · ligand · chains A
  • MUA · 9-methyl uric acid · ligand · chains A
  • OXY · Oxygen molecule · ion · chains A
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12080.550.7822empty
21860.490.7621XDS, OXY, MUA

Modifications

Observed in the structure: 1 modified (acetylation).

Compared structures

  • 4CW3 · Crystal structure of cofactor-free urate oxidase in complex with the 5-peroxo derivative… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.